BAYN
BAYER AG NA O.N.
Stock XETRA / Francfort – Stock Market Prices, News & Analysis
Bayer is a multinational conglomerate in the fields of health and agriculture, offering products and services in pharmaceuticals, animal health, and agrochemicals.
BAYER AG NA O.N.
BAYN
Bayer is a multinational conglomerate in the fields of health and agriculture, offering products and services in pharmaceuticals, animal health, and agrochemicals.
Price history of BAYER AG NA O.N.
Price history of BAYER AG NA O.N.
Performance & Momentum
Bayer rallies on restructuring and medical advances
After years of disappointing performance, Bayer's stock has surged 88% since early 2025, driven by restructuring announcements and strategic shifts in its pharmaceutical business. Concurrently, Bayer has launched a Phase IIa clinical trial for a treatment targeting the rare genetic Alport syndrome, strengthening its R&D pipeline. These combined factors have boosted investor confidence in the German group's turnaround potential, despite medium-term returns remaining negative.
Similar stocks to BAYER AG NA O.N.
Recent News
BAYER AG NA O.N.
Bayer Soars After US Supreme Court Backs Roundup Review
4 months agoBayer shares surged over 14% on the Frankfurt Stock Exchange after the US Solicitor General supported the Supreme Court's review of litigation related to Roundup, Monsanto's controversial product and a Bayer subsidiary. This shift could limit substantial compensation claims linked to alleged cancer risks associated with glyphosate. Additionally, Bayer advances its clinical pipeline by launching a Phase III study for its Mirena intrauterine device, strengthening its prospects in women's health.
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
